藥品參考
Beremagene geperpavec
Beremagene geperpavec is a medicine in the class miscellaneous.
- 藥物類別: Miscellaneous
最後更新 來源: EMA SmPC
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Miscellaneous
- ATC 代碼
- D03AX16
- 商品名
- 1
- 國家與市場
- 1
作用方式
Gene therapy using a replication-defective HSV-1 vector carrying COL7A1. After cutaneous application it transduces keratinocytes and fibroblasts, and the vector genome stays in the nucleus without integrating into host DNA. The cells then produce COL7, which forms anchoring fibrils that hold epidermis and dermis together.
成人常用劑量（仿單摘要）
Wounds in dystrophic epidermolysis bullosa: applied cutaneously to wounds once a week in small droplets in a grid pattern about 1 cm by 1 cm apart; maximum total weekly dose for adults 2 mL (4×109 PFU). Apply until wounds close; prioritise re-opened wounds; do not give if no wounds are present.
懷孕與哺乳
- 懷孕
- Unknown Topical gene therapy gel; no human data. EU label: not recommended in pregnancy. US: advise effective contraception during treatment. Pregnant people should not prepare or apply the gel and should avoid treated wounds and dressings.
- 哺乳
- Unknown No data on milk presence or infant effects. EU label: a risk cannot be excluded; decide whether to stop breastfeeding or therapy. US: weigh benefit. Avoid infant contact with treated wounds.
已通報的副作用
- Chills
- Pruritus
- Cough
- Rhinorrhea
- Erythema
- Rash
禁忌症
- Hypersensitivity to the active substance or to any of the excipients.
哪些人需要特別留意
- Do not apply to wounds with confirmed or suspected squamous cell carcinoma; other wounds may still be treated.
- Risk of transmission of infectious agents exists; monitor patients for signs and symptoms of infection after treatment.
- Contains genetically modified organisms; protective equipment (gloves, mask, eye protection) should be worn when handling. Pregnant women should not prepare, administer or handle dressing waste.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
Pro+ 會員專屬
解鎖完整頁面
建立帳號並開始 Pro+ 試用，即可開啟 Beremagene geperpavec 的完整藥品專論：劑量、懷孕與哺乳、副作用、警示及所有交互作用。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
在網頁版免費試用 Pro+ 14 天，無需信用卡。
同類別的其他藥品
常見問題
What is Beremagene geperpavec used for?
Beremagene geperpavec is a medicine in the class miscellaneous.
What side effects have been reported with Beremagene geperpavec?
Chills, Pruritus, Cough, Rhinorrhea, Erythema, Rash.
Can Beremagene geperpavec be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Topical gene therapy gel; no human data. EU label: not recommended in pregnancy. US: advise effective contraception during treatment. Pregnant people should not prepare or apply the gel and should avoid treated wounds and dressings. Breastfeeding: Unknown. No data on milk presence or infant effects. EU label: a risk cannot be excluded; decide whether to stop breastfeeding or therapy. US: weigh benefit. Avoid infant contact with treated wounds.
What does Beremagene geperpavec interact with?
MediHelp does not list a checked interaction for Beremagene geperpavec yet. Always tell your pharmacist about every medicine you take.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
